Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
A Pilot Trial of Stereotactic Body Radiation Therapy (SBRT) to Induce Tumor Hyperemia in Combination With Transarterial Chemoembolization (TACE) for Unresectable Hepatocellular Carcinoma
Sponsor: Ohio State University Comprehensive Cancer Center
Listed as NCT02507765, this PHASE1 trial focuses on Child-Pugh Class A and Child-Pugh Class B and remains completed. Sponsored by Ohio State University Comprehensive Cancer Center, it has been updated 15 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE1
Phase: NA → PHASE1
-
Oct 2021 — Nov 2021 [monthly]
Completed NA
-
May 2021 — Oct 2021 [monthly]
Completed NA
Status: Suspended → Completed
▶ Show 10 earlier versions
-
Jan 2021 — May 2021 [monthly]
Suspended NA
-
Aug 2020 — Jan 2021 [monthly]
Suspended NA
-
Nov 2019 — Aug 2020 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jun 2018 — Nov 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Suspended → Recruiting
-
Feb 2018 — Mar 2018 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Nov 2017 — Feb 2018 [monthly]
Recruiting NA
-
Jul 2017 — Nov 2017 [monthly]
Recruiting NA
-
Feb 2017 — Jul 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University Comprehensive Cancer Center
- Varian Medical Systems
For direct contact, visit the study record on ClinicalTrials.gov .